Vaccitech is a leading clinical-stage biotechnology company, focusing on the development and commercialization of novel vaccines and immunotherapeutics. With a cutting-edge platform based on viral vector technology, Vaccitech aims to address global health challenges and improve patient outcomes. The company’s strong track record and strategic partnerships position it as a key player in the rapidly evolving biotech industry.
